Clinical trial / 2014
In a pilot trial of IBS patients, ginger was well tolerated but did not perform better than placebo in reducing symptoms.
Forty-five IBS patients were randomized to receive placebo, 1 g of ginger, or 2 g of ginger daily for 28 days. Responders (defined as having at least a 25% reduction in IBS-SS) made up 57.1% of the placebo group, 46.7% of the 1 g ginger group, and 33.3% of the 2 g ginger group. Adequate relief was reported by 53.3% on placebo and 53.3% in both ginger groups combined. Side effects were mild, occurring in 35.7% of the placebo group and 16.7% of the ginger groups.
- Study type
- Double-blind randomized controlled pilot trial
- Who was studied
- 45 irritable bowel syndrome (IBS) patients
- What was measured
- IBS severity scale (IBS-SS) response (>=25% reduction), adequate relief of symptoms, and side effects
THE PAPER
Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial.
van Tilburg MA, Palsson OS, Ringel Y, Whitehead WE. Complement Ther Med, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.